The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-methyl-N-(2-methylquinolin-8-yl)-5-nitrobenzenesulfonamide ID: ALA403922
PubChem CID: 16759952
Max Phase: Preclinical
Molecular Formula: C17H15N3O4S
Molecular Weight: 357.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2cccc(NS(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2n1
Standard InChI: InChI=1S/C17H15N3O4S/c1-11-6-9-14(20(21)22)10-16(11)25(23,24)19-15-5-3-4-13-8-7-12(2)18-17(13)15/h3-10,19H,1-2H3
Standard InChI Key: GANMCBAUYLIAOL-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.1929 -2.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9122 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9091 -0.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1909 -0.5268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4799 -1.7672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4823 -0.9414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7694 -0.5281 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0536 -0.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0553 -1.7687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7687 -2.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1860 0.2982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8979 0.7150 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.6050 1.1322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3160 0.0037 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4837 1.4285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3192 0.7256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0256 1.1420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0183 1.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2986 2.3671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5952 1.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8754 2.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7474 0.7356 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4582 1.1545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7548 -0.0894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3392 -0.5271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
5 6 1 0
12 13 1 0
2 3 1 0
12 14 2 0
6 7 2 0
12 15 2 0
13 16 2 0
7 8 1 0
16 17 1 0
3 4 2 0
17 18 2 0
8 9 2 0
18 19 1 0
4 6 1 0
19 20 2 0
20 13 1 0
9 10 1 0
20 21 1 0
10 5 2 0
1 2 2 0
4 11 1 0
22 23 2 0
22 24 1 0
17 22 1 0
5 1 1 0
8 25 1 0
M CHG 2 22 1 24 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.39Molecular Weight (Monoisotopic): 357.0783AlogP: 3.56#Rotatable Bonds: 4Polar Surface Area: 102.20Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.73CX Basic pKa: 4.25CX LogP: 3.20CX LogD: 2.63Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.57Np Likeness Score: -2.15
References 1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS.. (2008) Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation., 18 (1): [PMID:18024113 ] [10.1016/j.bmcl.2007.10.100 ]